WANG XIAOLIN (See Remarks) received a stock award from REVOLUTION MEDICINES, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/4/2025ACC: 0001610717-25-000051
Officer· See Remarks
Since Mar 2021
+85.50K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
85.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+19K
Price / share
—
Trade value
—
% of position
22.1%
3/1/2025
86.04K→105.04K
Total
Net shares
+19K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/1/2025 | A · Award | +19K | — | — | 22.1% | 86.04K | 105.04K |
| Total | +19K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
66.50K shares
Shares
+66.50K
Strike price
40.74
Held after
66.50K
Exercisable
—
3/1/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock66.50K shares | 3/1/2025 | A · Award | +66.50K | 40.74 | — | 66.50K |